Autres langues Avacta Group Plc

Actions

Marché Fermé - London S.E. Autres places de cotation 17:35:29 31/05/2024			Varia. 5j.	Varia. 1 janv.
40,4 ^GBX	-6,05 %		-8,39 %	-65,32 %

23/05	Windward remporte un contrat ; Kodal progresse à Bougouni	AN
23/05	Avacta Group plc annonce l'achèvement avec succès de la première cohorte et le dosage de trois patients de la deuxième cohorte dans le bras 2 de l'essai de phase 1 d'Ava6000 d'Avacta	CI

Windward wins deal; Kodal progresses at Bougouni	23/05
Avacta Group plc Announces Successful Completion of First Cohort and Dosing of Three Patients of the Second Cohort in Arm 2 of Avacta's Ava6000 Phase 1 Trial	23/05
AstraZeneca target raised; Antofagasta lowered	07/05
Avacta picks Christina Coughlin to replace long-serving CEO	01/05
EARNINGS: Avacta sales jump; Poolbeg loss narrows; Digital 9 NAV down	30/04
Avacta Group CEO Steps Down; Successor Appointed	30/04
Transcript : Avacta Group Plc, 2023 Earnings Call, Apr 30, 2024	30/04
Avacta Group Plc Reports Earnings Results for the Full Year Ended December 31, 2023	30/04
Avacta Group plc Announces Chief Executive Officer Changes	30/04
First Tin updates Tellerhauser estimates	22/04
Transcript : Avacta Group Plc - Special Call	10/04
Avacta Group plc Reports Data from the Ongoing Phase 1 Clinical Trial of AVA6000 At the AACR Annual Meeting	09/04
Avacta doses third patient in drug conjugate trial for tumour tissue	21/03
Avacta shareholders give AGM go-ahead to issue new shares	18/03
EARNINGS AND TRADING: Harland & Wolff wins major Falklands contract	05/03
Avacta Group Upsizes Share Placement Amid Strong Investor Demand	29/02
Avacta increases placing size to GBP26 million thanks to strong demand	29/02
AIM WINNERS & LOSERS: Beacon Energy and Avacta fall on fundraise	29/02
Avacta plans fundraise to fund clinical development	28/02
Avacta says new head of R&D Coughlin brings "deep expertise"	19/01

Aucun résultat pour cette recherche